Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Drugs

• Publication date

  2019-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40265-019-01182-1PMID 31429065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs

  2018cited by this paper
• GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.

  2018cited by this paper
• Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients

  2017cited by this paper
• Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patient

  2017cited by this paper
• Influence of magnesium and parathyroid hormone on cisplatin-induced nephrotoxicity in esophageal squamous cell carcinoma.

  2017cited by this paper
• Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer

  2017cited by this paper
• Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity.

  2017cited by this paper
• Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study

  2017cited by this paper
• Protection of kidneys by magnesium in cisplatin chemotherapy: a fight between two metals.

  2017cited by this paper
• Multivariate analysis of risk factors for cisplatin‐induced nephrotoxicity in gynecological cancer

  2017cited by this paper
• A retrospective evaluation of furosemide and mannitol for prevention of cisplatin‐induced nephrotoxicity

  2017cited by this paper
• A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

  2017cited by this paper
• Mannitol for the prevention of cisplatin-induced nephrotoxicity: A retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center

  2017cited by this paper
• Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity

  2017cited by this paper
• Short hydration regimen with magnesium supplementation prevents cisplatin-induced nephrotoxicity in lung cancer: a retrospective analysis

  2017cited by this paper
• Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.

  2016cited by this paper
• Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer.

  2016cited by this paper
• Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial

  2016cited by this paper
• Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy

  2016cited by this paper
• Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients

  2016cited by this paper
• The efficacy of theophylline in preventing cisplatin-related nephrotoxicity in patients with cancer

  2016cited by this paper
• Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

  2015cited by this paper
• [Associations between Clinical Factors and Acute Renal Failure Due to Cisplatin Combination Chemotherapy for Lung Cancer].

  2015cited by this paper
• [Feasibility of short volume hydration in patients with lung cancer treated with Cisplatin-containing chemotherapy].

  2015cited by this paper
• Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin.

  2015cited by this paper
• Meta-analysis in clinical trials revisited.

  2015cited by this paper
• Japan as the front‐runner of super‐aged societies: Perspectives from medicine and medical care in Japan

  2015cited by this paper
• Effect of mannitol and magnesium on cisplatin-induced nephrotoxicity: A retrospective evaluation.

  2015cited by this paper
• Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial

  2015cited by this paper
• Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1

  2015cited by this paper
• Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity

  2014cited by this paper
• Comparison of Short and Continuous Hydration Regimen in Chemotherapy Containing Intermediate- to High-Dose Cisplatin

  2014cited by this paper
• Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study

  2014cited by this paper
• Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.

  2014cited by this paper
• Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.

  2014cited by this paper
• Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol

  2014cited by this paper
• Evaluation of the protective effect of Cystone® against cisplatin-induced nephrotoxicity in cancer patients, and its influence on cisplatin antitumor activity

  2014cited by this paper
• Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection

  2014cited by this paper
• Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case–control study

  2014cited by this paper
• [Magnesium premedication prevents Cisplatin-induced nephrotoxicity in patients with esophageal and hypopharyngeal cancer].

  2013cited by this paper
• The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study

  2013cited by this paper
• The Risk Factors of Severe Acute Kidney Injury Induced by Cisplatin

  2013cited by this paper
• The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebo-controlled study

  2012cited by this paper
• Suboptimal magnesium status in the United States: are the health consequences underestimated?

  2012cited by this paper
• Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer.

  2012cited by this paper
• Ameliorative effects of SLC22A2 gene polymorphism 808 G/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients.

  2012cited by this paper
• Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events

  2012cited by this paper
• KDIGO (Kidney Disease: Improving Global Outcomes) Criteria Could Be a Useful Outcome Predictor of Cisplatin-Induced Acute Kidney Injury

  2012cited by this paper
• Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients

  2012cited by this paper
• Abstracts

  2011cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias.

  2011cited by this paper
• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

  2011cited by this paper
• Acute kidney injury associates with increased long-term mortality.

  2010cited by this paper
• The status of platinum anticancer drugs in the clinic and in clinical trials.

  2010cited by this paper
• A comparison of the rates of cisplatin (cDDP) - induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure

  2010cited by this paper
• PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

  2010cited by this paper
• Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity

  2009cited by this paper
• Systematic Reviews [ressource électronique]. CRD's guidance for undertaking reviews in health care

  2009cited by this paper
• Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function

  2009cited by this paper
• Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats

  2009cited by this paper
• The RIFLE criteria and mortality in acute kidney injury: A systematic review.

  2008cited by this paper
• Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

  2008cited by this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cited by this paper
• Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin

  2008cited by this paper
• Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study.

  2008cited by this paper
• Cisplatin Nephrotoxicity: A Review

  2007cited by this paper
• A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints

  2006cited by this paper
• Understanding interobserver agreement: the kappa statistic.

  2005cited by this paper
• Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

  2005cited by this paper
• Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Cisplatin nephrotoxicity

  2004cited by this paper
• Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.

  2004cited by this paper
• Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine

  2004cited by this paper
• Cisplatin nephrotoxicity.

  2003cited by this paper
• Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

  2003cited by this paper
• The Cancer Transition in Japan since 1951

  2002cited by this paper
• Magnesium and trace elements in the elderly: intake, status and recommendations.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancer.

  2001cited by this paper
• Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.

  2001cited by this paper
• The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

  2000cited by this paper
• A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors

  2000cited by this paper
• Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.

  1999cited by this paper
• Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

  1998cited by this paper
• Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

  1997cited by this paper
• Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

  1997cited by this paper
• Cisplatin‐induced renal effects and thromboxane A2 receptor blockade

  1997cited by this paper
• The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients

  1997cited by this paper
• Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

  1996cited by this paper
• The Protective Effect of Methylprednisolone against Cisplatin‐Induced Nephrotoxicity in Patients with Urothelial Tumors

  1996cited by this paper
• Phase I trial of cisplatin in combination with glutathione.

  1994cited by this paper
• Trends in cancer mortality, incidence and survival in Japan.

  1992cited by this paper
• The protective potential of the combination of verapamil and cimetidine on cisplatin‐induced nephrotoxicity in man

  1987cited by this paper
• Influence of captopril on cis-diamminedichloroplatinum-induced renal toxicity.

  1985cited by this paper
• Minireview. The nephrotoxicity of cisplatin.

  1983cited by this paper
• The nephrotoxicity of cisplatin

  1983cited by this paper
• Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis.

  1979cited by this paper
• Platinum nephrotoxicity.

  1978cited by this paper

• Dunaliella salina-Loaded Diosmetin Carriers Alleviate Oxidative Stress and Inflammation in Cisplatin-Induced Acute Kidney Injury via PI3K/AKT Pathway

  2026cites this paper
• Advances in the clinical applications of sodium thiosulphate

  2026cites this paper
• Bimodal Visualization of Mitochondrial Viscosity Remodeling, Morphological Dynamics and Interorganelle Networks in Acute Kidney Injury.

  2025cites this paper
• Icaritin Ameliorates Cisplatin‐Induced Mitochondrial Metabolic Dysfunction‐Associated Nephrotoxicity and Synergistically Potentiates Its Antitumor Efficacy

  2025cites this paper
• N-Acetylcysteine Role in Maintaining Renal Function in Cancer Patients with Cisplatin-Based Chemotherapy

  2025cites this paper
• Mannitol for prevention of cisplatin-induced nephrotoxicity: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Tetrahedral framework nucleic acids: Nanokeys unlocking a new Era of precision biomedicine.

  2025cites this paper
• Evaluation of the nephroprotective role of cystone in patients receiving cisplatin-based chemotherapy

  2025cites this paper
• Exploring hypomagnesemia: A critical and forgotten aspect of cancer patient management

  2025cites this paper
• Synergistic effect of piperine on curcumin in cisplatin-induced nephrotoxicity through DNA fragmentation and cytokines gene expressions.

  2025cites this paper
• Hydrogen sulfide protects against cisplatin-induced experimental nephrotoxicity in animal models: a systematic review and meta-analysis

  2025cites this paper
• Diagnostic and Prognostic Potential of SH3YL1 and NOX4 in Muscle-Invasive Bladder Cancer

  2025cites this paper
• Both carvedilol and cimetidine alleviate cisplatin-induced nephrotoxicity via downregulating OCT2.

  2025cites this paper
• Short Hydration Regimen in Cisplatin-Based Chemotherapy and Its Impact on Nephrotoxicity: A Unicentric Prospective Study

  2025influential citation
• Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial

  2024cites this paper
• A DNA nanostructure‐Hif‐1α inducer complex as novel nanotherapy against cisplatin‐induced acute kidney injury

  2024cites this paper
• Slc25a21 in cisplatin-induced acute kidney injury: a new target for renal tubular epithelial protection by regulating mitochondrial metabolic homeostasis

  2024cites this paper
• Nanoformulations in the treatment of lung cancer: current status and clinical potential

  2024cites this paper
• Multi-omics analysis reveals the protective effects of Chinese yam polysaccharide against cisplatin-induced renal interstitial fibrosis.

  2024cites this paper
• Evaluating the effects of intravenous magnesium sulfate for prevention of colistin induced acute kidney injury: an open-label, placebo-controlled, block randomized clinical trial

  2024influential citation
• Total alkaloids of Aconitum carmichaelii Debx alleviate cisplatin-induced acute renal injury by inhibiting inflammation and oxidative stress related to gut microbiota metabolism.

  2024cites this paper
• Relationship between magnesium dosage and the preventive effect on cisplatin-induced nephrotoxicity: meta-analysis and meta-regression analysis

  2024cites this paper
• The IDH1-R132H mutation aggravates cisplatin-induced acute kidney injury by promoting ferroptosis through disrupting NDUFA1 and FSP1 interaction

  2024cites this paper
• Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches

  2024cites this paper
• Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin

  2024cites this paper
• Multifunctional Nanosystem Based on Ultrasmall Carbon Dots for the Treatment of Acute Kidney Injury.

  2024cites this paper
• Pre-activation of hypoxia-inducible factor 1-α using prolyl hydroxylase domain inhibitors reduces cisplatin-induced nephrotoxicity

  2024cites this paper
• Oleanolic Acid Acetate Alleviates Cisplatin-Induced Nephrotoxicity via Inhibition of Apoptosis and Necroptosis In Vitro and In Vivo

  2024cites this paper
• Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational Study

  2024cites this paper
• Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review

  2023cites this paper
• Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential

  2023cites this paper
• Crosstalk between COVID-19 Infection and Kidney Diseases: A Review on the Metabolomic Approaches

  2023cites this paper
• Neonatal‐Tissue‐Derived Extracellular Vesicle Therapy (NEXT): A Potent Strategy for Precision Regenerative Medicine

  2023cites this paper
• Asiatic acid alleviates cisplatin-induced renal fibrosis in tumor-bearing mice by improving the TFEB-mediated autophagy-lysosome pathway.

  2023cites this paper
• A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation

  2023cites this paper
• 14-3-3ζ targets β-catenin nuclear translocation to maintain mitochondrial homeostasis and promote the balance between proliferation and apoptosis in cisplatin-induced acute kidney injury.

  2023cites this paper
• Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects

  2022cites this paper
• Current Indications for Intraarterial Chemotherapy in Neurointerventional Surgery

  2022cites this paper
• Hypomagnesemia in Patients With Cancer: The Forgotten Ion.

  2022cites this paper
• Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.

  2022cites this paper
• Co-delivery of celastrol and lutein with pH sensitive nano micelles for treating acute kidney injury.

  2022cites this paper
• Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity

  2022cites this paper
• The Intersection of Acute Kidney Injury and Non-Coding RNAs: Inflammation

  2022cites this paper
• Matrine alleviates cisplatin‐induced acute kidney injury by inhibiting mitochondrial dysfunction and inflammation via SIRT3/OPA1 pathway

  2022cites this paper
• microRNA‐486‐5p is implicated in the cisplatin‐induced apoptosis and acute inflammation response of renal tubular epithelial cells by targeting HAT1

  2022cites this paper
• Loss of sphingosine kinase 2 protects against cisplatin induced-kidney injury.

  2022cites this paper
• β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress.

  2022cites this paper
• Mitochondrial translocation of P66Shc aggravates cisplatin- induced AKI by promoting ferroptosis.

  2022cites this paper
• Sinapic acid alleviates cisplatin-induced acute kidney injury by mitigating oxidative stress and apoptosis

  2022cites this paper
• Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial

  2022cites this paper
• Reactive Oxygen Species- and Cell-Free DNA-Scavenging Mn3O4 Nanozymes for Acute Kidney Injury Therapy.

  2022cites this paper
• Unveiling the interaction profile of cisplatin with gold-supported magnesia film

  2021cites this paper
• Acute kidney injury in cancer patients

  2021cites this paper
• Seizure and delirium secondary to carboplatin and pantoprazole therapy‐induced hypomagnesemia in a cancer patient

  2021cites this paper
• Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells

  2021cites this paper
• Current role of nanoparticles in the treatment of lung cancer

  2021cites this paper
• The salutary action of melatonin and betaine, given singly or concomitantly, on cisplatin-induced nephrotoxicity in mice

  2021cites this paper
• Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin

  2021cites this paper
• Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis

  2021cites this paper
• A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity

  2021cites this paper
• HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential

  2021cites this paper
• Conventional Chemotherapy Nephrotoxicity.

  2021cites this paper
• Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury

  2021cites this paper
• Cisplatin Mouse Models: Treatment, Toxicity and Translatability

  2021influential citation
• Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum

  2021influential citation
• Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

  2021cites this paper
• The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: an ambispective cohort study

  2021cites this paper
• Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.

  2020cites this paper
• Phenylenediamine-based Carbon Nanodots Alleviate Acute Kidney Injury via Preferential Renal Accumulation and Antioxidant Capacity.

  2020cites this paper
• Omeprazole attenuates cisplatin-induced kidney injury through suppression of the TLR4/NF-κB/NLRP3 signaling pathway.

  2020cites this paper
• Effect of concomitant treatment of curcumin and melatonin on cisplatin-induced nephrotoxicity in rats.

  2020cites this paper
• Calcium dobesilate prevents cisplatin-induced nephrotoxicity by modulating oxidative and histopathological changes in mice

  2020cites this paper
• CMAR_A_262674 7199..7207

  2020cites this paper
• Possibility of magnesium supplementation for supportive treatment in patients with COVID-19

  2020cites this paper
• Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study

  2020cites this paper
• The Effect of Admission Serum Magnesium on the Acute Kidney Injury Among Patients with Malignancy

  2020cites this paper